Plasminogen activation and breast cancer
Mira-y-Lopez, Rafael.
Ciênc. cult. (Säo Paulo)
; 46(1/2): 34-45, Jan.-Abr. 1994.
Artículo en Inglés | LILACS | ID: lil-172012
Documentos relacionados
Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1).
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.
The Multifaceted Role of Plasminogen in Cancer.
Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Role of tissue-type plasminogen activator in salicylic acid-induced sloughing of human corn tissue.
[Relationship between plasminogen activator, plasminogen activator inhibitor and Sertoli cells].
[Plasminogen activators and their function].
Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.